Exhibit


Exhibit 10.302


SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of September 30, 2015, among Par Pharmaceutical Companies, Inc., a Delaware corporation, Par Pharmaceutical, Inc., a Delaware corporation, Anchen Incorporated, a Delaware corporation, Par, Inc., a Delaware corporation, Anchen Pharmaceuticals, Inc., a California corporation, JHP Group Holdings, Inc., a Delaware corporation, JHP Acquisition, LLC, a Delaware limited liability company, Par Sterile Products, LLC, a Delaware limited liability company, Kali Laboratories, Inc., a New Jersey corporation, Innoteq, Inc., a Connecticut corporation, Par Laboratories Europe, Ltd., a company organized under the laws of the United Kingdom and Endo Finance IV Limited, a private limited company incorporated under the laws of Ireland (each, a “Guaranteeing Subsidiary” and collectively, the “Guaranteeing Subsidiaries”), subsidiaries of Endo Designated Activity Company, a private limited company incorporated under the laws of Ireland (the “Company”), the Issuers, the other Guarantors (both, as defined in the Indenture referred to below) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).
W I T N E S S E T H
WHEREAS, Endo Finance LLC, a Delaware limited liability company, and Endo Finco Inc., a Delaware corporation, have heretofore executed and delivered to the Trustee an indenture, dated as of May 6, 2014, as supplemented by a supplemental indenture, dated as of May 28, 2014, a supplemental indenture, dated as of July 10, 2014, a supplemental indenture, dated as of August 11, 2014, a supplemental indenture, dated as of December 22, 2014, a supplemental indenture, dated as of February 3, 2015, a supplemental indenture, dated as of March 20, 2015, a supplemental indenture, dated as of March 27, 2015, a supplemental indenture, dated as of June 24, 2015, and a supplemental indenture, dated as of July 9, 2015, in each case, among the Issuers, the Guarantors party thereto and the Trustee (as so supplemented, the “Indenture”), providing for the issuance of 7.25% Senior Notes due 2022 (the “Notes”);
WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiaries shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiaries shall unconditionally guarantee all of the Issuers’ Obligations under the Notes and the Indenture on the terms and conditions set forth herein (the “Note Guarantee”); 
WHEREAS, this Supplemental Indenture has not resulted in a material modification of the Notes for Foreign Account Tax Compliance Act purposes; and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiaries and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:

1


Exhibit 10.302


1.CAPITALIZED TERMS.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.AGREEMENT TO GUARANTEE.  Each of the Guaranteeing Subsidiaries hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Note Guarantee and in the Indenture including but not limited to Article 10 thereof.
3.NO RECOURSE AGAINST OTHERS.  No director, officer, employee, incorporator or stockholder of the Issuers or any Guarantor, as such, will have any liability for any obligations of the Issuers or the Guarantors under the Notes, the Indenture, this Supplemental Indenture, the Note Guarantees or for any claim based on, in respect of, or by reason of, such obligations or their creation.  Each Holder of Notes by accepting a Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Notes.  The waiver may not be effective to waive liabilities under the federal securities laws.

2


Exhibit 10.302


4.NEW YORK LAW TO GOVERN; WAIVER OF JURY TRIAL.  THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.  EACH OF THE ISSUERS AND THE GUARANTORS CONSENTS AND IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY NEW YORK STATE OR U.S. FEDERAL COURT LOCATED IN THE BOROUGH OF MANHATTAN, CITY OF NEW YORK, COUNTY OF NEW YORK, STATE OF NEW YORK IN RELATION TO ANY LEGAL ACTION OR PROCEEDING (I) ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS INDENTURE, AS SUPPLEMENTED, THE NOTES, THE GUARANTEES AND ANY RELATED DOCUMENTS AND/OR (II) ARISING UNDER ANY U.S. FEDERAL OR U.S. STATE SECURITIES LAWS IN RESPECT OF THE NOTES, THE GUARANTEES AND ANY SECURITIES ISSUED PURSUANT TO THE TERMS OF THE INDENTURE, AS SUPPLEMENTED.  EACH OF THE ISSUERS AND THE GUARANTORS WAIVES ANY OBJECTION TO PROCEEDINGS IN ANY SUCH COURTS, WHETHER ON THE GROUND OF VENUE OR ON THE GROUND THAT THE PROCEEDINGS HAVE BEEN BROUGHT IN AN INCONVENIENT FORUM.  EACH OF THE ISSUERS AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, SHALL APPOINT CT CORPORATION SYSTEM, 111 EIGHTH AVENUE, 13TH FLOOR, NEW YORK, NY 10011, AS ITS AGENT FOR SERVICE OF PROCESS IN ANY SUCH SUIT, ACTION OR PROCEEDING AND AGREES THAT SERVICE OF PROCESS UPON SAID AUTHORIZED AGENT SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON IT IN ANY SUCH SUIT, ACTION OR PROCEEDING. EACH OF THE ISSUERS AND THE GUARANTORS AGREES TO DELIVER, UPON THE EXECUTION AND DELIVERY OF THIS SUPPLEMENTAL INDENTURE, A WRITTEN ACCEPTANCE BY SUCH AGENT OF ITS APPOINTMENT AS SUCH AGENT. EACH OF THE ISSUERS AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, FURTHER AGREES TO TAKE ANY AND ALL ACTION, INCLUDING THE FILING OF ANY AND ALL SUCH DOCUMENTS AND INSTRUMENTS, AS MAY BE REASONABLY NECESSARY TO CONTINUE SUCH DESIGNATION AND APPOINTMENT OF CT CORPORATION SYSTEM IN FULL FORCE AND EFFECT FOR SO LONG AS THE INDENTURE, AS SUPPLEMENTED, REMAINS IN FORCE.  EACH OF THE ISSUERS, THE TRUSTEE AND THE GUARANTORS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.
5.COUNTERPARTS.  The parties may sign any number of copies of this Supplemental Indenture.  Each signed copy (which may be provided via facsimile or other electronic transmission) shall be an original, but all of them together represent the same agreement.  
6.EFFECT OF HEADINGS.  The Section headings herein are for convenience only and shall not affect the construction hereof.
7.THE TRUSTEE.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiaries and the Issuers.

3


Exhibit 10.302


[Signature Pages Follow]

4


Exhibit 10.302


IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.


	
				
	PAR PHARMACEUTICAL COMPANIES, INC.

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	PAR PHARMACEUTICAL, INC.

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ANCHEN INCORPORATED

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	PAR, INC.

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 









[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	JHP GROUP HOLDINGS, INC

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	JHP ACQUISITION, LLC

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	PAR STERILE PRODUCTS, LLC

	as a Guaranteeing Subsidiary

	by JHP ACQUISITION, LLC, as Manager

	by JHP GROUP HOLDINGS, INC., its manager

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ANCHEN PHARMACEUTICALS, INC

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	KALI LABORATORIES, INC.

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	INNOTEQ, INC.

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 













[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	PAR LABORATORIES EUROPE, LTD

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea
	 

	Name:
	Orla Dunlea
	 

	Title:
	Director
	 





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO FINANCE IV LIMITED

	as a Guaranteeing Subsidiary

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea
	 

	Name:
	Orla Dunlea
	 

	Title:
	Director
	 





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO FINANCE LLC

	as an Issuer

	by ENDO LUXEMBOURG FINANCE COMPANY I S.À R.L., its sole member

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	John D. Boyle
	 

	Name:
	John D. Boyle
	 

	Title:
	A Manager
	 

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Joost Tulkens
	 

	Name:
	Joost Tulkens
	 

	Title:
	B Manager
	 









[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO FINCO INC.

	as an Issuer

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Secretary 
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO LLC

	ENDO U.S. INC. 


	each, as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Secretary
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	DAVA PHARMACEUTICALS, INC.

	ENDO HEALTH SOLUTIONS, INC.

	ENDO PHARMACEUTICALS INC.

	ENDO PHARMACEUTICALS SOLUTIONS INC.

	ENDO PHARMACEUTICALS VALERA INC.

	GENERICS INTERNATIONAL (US PARENT), INC.

	GENERICS INTERNATIONAL (US MIDCO), INC.

	GENERICS INTERNATIONAL (US HOLDO), INC.

	GENERICS INTERNATIONAL (US), INC.

	AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.each, as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	GENERICS BIDCO I, LLC

	VINTAGE PHARMACEUTICALS, LLC

	GENERICS BIDCO II, LLC

	MOORES MILL PROPERTIES LLC

	WOOD PARK PROPERTIES LLC

	QUARTZ SPECIALITY PHARMACEUTICALS, LLC 

	each as a Guarantor

	by GENERICS INTERNATIONAL (US), INC.,

	its manager

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 









[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	LEDGEMENT ROYALTY SUB LLC

	each as a Guarantor

	by ENDO PHARMACEUTICALS SOLUTIONS INC.,

	its manager

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	DAVA International, LLC

	as a Guarantor

	by DAVA PHARMACEUTICALS, INC.,

	its sole member

	 

	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	DAVA CAPITAL MANAGEMENT, INC.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 



























































[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302






	
				
	AUXILIUM INTERNATIONAL HOLDINGS, INC.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	SLATE PHARMACEUTICALS, INC.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	TIMM MEDICAL TECHNOLOGIES, INC.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ACTIENT PHARMACEUTICALS LLC

	as a Guarantor

	 
	 
	 
	 

	By: AUXILIUM PHARMACEUTICALS, INC.,

	its manager

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 









[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302




	
				
	ACTIENT THERAPEUTICS LLC

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	AUXILIUM US HOLDINGS, LLC

	as a Guarantor

	 
	 
	 
	 

	By: AUXILIUM PHARMACEUTICALS, INC., 

	its manager 

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	AUXILIUM PHARMACEUTICALS, INC.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 











[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	70 MAPLE AVENUE, LLC

	as a Guarantor

	 
	 
	 
	 

	By: ACTIENT PHARMACEUTICALS LLC,

	its manager

	 
	 
	 

	By: AUXILIUM PHARMACEUTICALS, INC

	its manager

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 

	 

	 

	TIMM MEDICAL HOLDINGS, LLC

	its Guarantor

	 

	By: ACTIENT PHARMACEUTICALS LLC, 

	its manager

	 

	By: AUXILIUM PHARMACEUTICALS, INC.

	its manager 

	 

	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 

	 

	 

	 

	APHRODITE WOMEN'S HEALTH, LLC

	as a Guarantor 

	 

	By: AMERICAN MEDICAL SYSTEMS HOLDINGS, INC., 

	its manager

	 

	 

	By:
	/s/
	Deanna Voss
	 

	Name:
	Deanna Voss
	 

	Title:
	Assistant Secretary
	 





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302




	
				
	ENDO DESIGNATED ACTIVITY COMPANY

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 

	 

	 

	 

	ENDO VENTURES LIMITED 

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 

	 

	 

	 

	ENDO MANAGEMENT II LIMITED 

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO FINANCE LIMITED 

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 











[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO FINANCE II LIMITED

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO FINANCE III LIMITED

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 

	 

	 

	HAWK ACQUISITION IRELAND LIMITED

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO TOPFIN LIMITED

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO IRELAND FINANCE LIMITED

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea    
	 

	Name:
	Orla Dunlea    
	 

	Title:
	Director
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	PALADIN LABS CANADIAN HOLDING INC.

	as a Guarantor

	 
	 
	 
	 

	By:
	/s/
	Mark Beaudet
	 

	Name:
	Mark Beaudet
	 

	Title:
	President
	 

	 

	 

	 

	PALADIN LABS INC. 


	as a Guarantor

	 
	 
	 
	 

	By:
	/s/
	Mark Beaudet
	 

	Name:
	Mark Beaudet
	 

	Title:
	President
	 









[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO VENTURES BERMUDA LIMITED

	as a Guarantor

	 
	 
	 
	 

	By:
	/s/
	Susan Hall
	 

	Name:
	Susan Hall
	 

	Title:
	Director
	 

	 

	 

	 

	ENDO GLOBAL VENTURES

	as a Guarantor

	 
	 
	 
	 

	By:
	/s/
	Susan Hall
	 

	Name:
	Susan Hall
	 

	Title:
	Director
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	HAWK ACQUISITION ULC

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Laurence S. Smith
	 

	Name:
	Laurence S. Smith
	 

	Title:
	Director
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO BERMUDA FINANCE LIMITED 

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Robert J. Cobuzzi.
	 

	Name:
	Robert J. Cobuzzi.
	 

	Title:
	Director
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO NETHERLANDS B.V.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Robert J. Cobuzzi.
	 

	Name:
	Robert J. Cobuzzi.
	 

	Title:
	Managing Director A
	 

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Gert Jan Rietberg
	 

	Name:
	Gert Jan Rietberg
	 

	Title:
	Managing Director B
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO VENTURES CYPRUS LIMITED

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea
	 

	Name:
	Orla Dunlea
	 

	Title:
	Director
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	AUXILIUM UK LTD

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Orla Dunlea
	 

	Name:
	Orla Dunlea
	 

	Title:
	Director
	 





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO LUXEMBOURG HOLDING COMPANY           S.À R.L.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	John D. Boyle
	 

	Name:
	John D. Boyle
	 

	Title:
	A Manager
	 

	 
	 
	 
	 

	By:
	/s/
	Joost Tulkens
	 

	Name:
	Joost Tulkens
	 

	Title:
	B Manager
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO LUXEMBOURG FINANCE COMPANY I       S.À R.L.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	John D. Boyle
	 

	Name:
	John D. Boyle
	 

	Title:
	A Manager
	 

	 
	 
	 
	 

	By:
	/s/
	Joost Tulkens
	 

	Name:
	Joost Tulkens
	 

	Title:
	B Manager
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO LUXEMBOURG FINANCE COMPANY II      S.À R.L.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	John D. Boyle
	 

	Name:
	John D. Boyle
	 

	Title:
	A Manager
	 

	 
	 
	 
	 

	By:
	/s/
	Joost Tulkens
	 

	Name:
	Joost Tulkens
	 

	Title:
	B Manager
	 





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	ENDO US HOLDINGS LUXEMBOURG I HOLDING COMPANY S.À R.L.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	John D. Boyle
	 

	Name:
	John D. Boyle
	 

	Title:
	A Manager
	 

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Joost Tulkens
	 

	Name:
	Joost Tulkens
	 

	Title:
	B Manager
	 

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	 

	ENDO US HOLDINGS LUXEMBOURG II S.À R.L.

	as a Guarantor

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	John D. Boyle
	 

	Name:
	John D. Boyle
	 

	Title:
	A Manager
	 

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Joost Tulkens
	 

	Name:
	Joost Tulkens
	 

	Title:
	B Manager
	 





[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]


Exhibit 10.302


	
				
	WELLS FARGO BANK, NATIONAL ASSOCIATION, 

	as a Trustee

	 
	 
	 
	 

	 
	 
	 
	 

	By:
	/s/
	Yana Kislenko 

	 

	Name:
	Yana Kislenko 

	 

	Title:
	Vice President
	 







[Signature Page to 7.25% Senior Notes due 2022 Supplemental Indenture]